匹兹堡大学的研究提出共同使用多巴胺受体阻滞剂来降低抗精神病药物导致的糖尿病风险。 University of Pittsburgh research proposes co-administering dopamine receptor blockers to reduce diabetes risk from antipsychotic meds.

匹兹堡大学的研究表明，广泛使用的抗精神病药物可以降低患糖尿病的风险。 University of Pittsburgh research suggests a potential approach to reducing diabetes risk from widely prescribed antipsychotic meds. 同时使用阻断大脑和胰腺多巴胺受体的药物可能会限制血糖紊乱等代谢副作用。 Co-administering drugs that block dopamine receptors in the brain and pancreas may limit metabolic side effects like dysglycemia. 这项研究可以解释为什么体重控制药物对控制抗精神病药物引起的血糖紊乱不那么有效。 This research could explain why weight control medications aren't as effective in controlling dysglycemia caused by antipsychotics.